CapeHaven
◆ Fund Size
$10M
◆ Location
United States
◆ Activity
Statusraising
◆ Links
◆ Share this fund
◆ Investment Thesis
CapeHaven specializes in advancing early-stage therapeutics from academia to a financeable business, bridging the gap between academic discoveries and commercialization in order to deliver life-saving therapies to patients in need.
◆ About CapeHaven
A Yale-based biotech venture creation platform that combines scientific expertise, developmental planning, infrastructure, and capital to transform Yale research into early-stage therapeutic companies. The platform takes a multi-asset approach, housing multiple distinct biotech assets under a single parent company structure.
◆ Sectors
◆ Stages
◆ Geography Focus
◆ Team
| Name | Title | Role | Links |
|---|---|---|---|
| Kevin Rakin | Co-founder | — | |
| Mike Dillon | Co-founder | — | |
| Ranjit Bindra | Co-founder | — | |
| Seth Herzon | Co-founder | — |
◆ Notable Investments
◆ FAQ
What does CapeHaven invest in?
CapeHaven invests in Biotech at the pre-seed and seed stages.
Which geographies does CapeHaven focus on?
CapeHaven focuses on United States, and is headquartered in United States.